Questions and Answers from the F.I.X./Metered-Dose Inhalers vs Nebulizers/Amiodarone Infusion Rate in Cardiac Arrest/Lidocaine as an Additive to KCl/Review of the New NCEP Recommendations for the Management of High Cholesterol
Restricted accessResearch articleFirst published online September, 2001
Questions and Answers from the F.I.X./Metered-Dose Inhalers vs Nebulizers/Amiodarone Infusion Rate in Cardiac Arrest/Lidocaine as an Additive to KCl/Review of the New NCEP Recommendations for the Management of High Cholesterol
The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers to The Formulary Monograph Service at http://theformulary.com, or you may log on through drugfacts.com. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X., please call 800-322-4349.
Get full access to this article
View all access options for this article.
References
1.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA.2001; 285(19): 2486–97.
2.
LauerM.S., FontanarosaP.B.Updated guidelines for cholesterol management. JAMA.2001; 285(19): 2508–9.
